Kavanagh A M, Giles G G, Mitchell H, Cawson J N
Australian Research Centre in Sex, Health and Society, La Trobe University, Melbourne, Victoria, Australia.
J Med Screen. 2000;7(2):105-10. doi: 10.1136/jms.7.2.105.
To examine whether the accuracy of screening mammography varies according to symptomatic status reported at the time of screening.
Victoria, Australia, where free biennial screening is provided to women aged 40 and older.
We examined the sensitivity, specificity, and the positive predictive value of screening mammography by symptom status in 106,826 women from Victoria, who attended for first round mammography in 1994 and who did not have a personal history of breast cancer. Symptomatic status was divided into the following categories: asymptomatic; significant symptoms, if the woman reported a breast lump and/or blood stained or watery nipple discharge; and other symptoms, if reported. Unconditional logistic regression modelling was used to adjust for age, use of hormone replacement therapy (HRT), and family history.
Sensitivity was lower for women with other symptoms (60.0%) than asymptomatic women (75.6%), or women with significant symptoms (80.8%). Specificity was lower for women with significant symptoms (73.7%) than asymptomatic women (94.9%), or women with other symptoms (95.4%). Among women who had invasive cancer detected during screening interval, women with other symptoms were more likely to get a false negative result (odds ratio 1.79, 95% confidence interval 1.03 to 3.04) than asymptomatic women, after adjusting for age, use of HRT, and family history.
The lower sensitivity in women with other symptoms requires further investigation. Possible explanations include increased breast density and poor image quality. The high sensitivity in women with significant symptoms is probably due to more cautious radiological practice, which has also resulted in low specificity in this group.
探讨乳腺钼靶筛查的准确性是否因筛查时报告的症状状态而异。
澳大利亚维多利亚州,为40岁及以上女性提供免费的两年一次的筛查。
我们在来自维多利亚州的106,826名女性中,根据症状状态检查了乳腺钼靶筛查的敏感性、特异性和阳性预测值。这些女性于1994年参加了第一轮钼靶检查,且无乳腺癌个人史。症状状态分为以下几类:无症状;有明显症状,即女性报告有乳房肿块和/或乳头血性或水样溢液;以及报告有其他症状。采用无条件逻辑回归模型对年龄、激素替代疗法(HRT)的使用和家族史进行调整。
有其他症状的女性的敏感性(60.0%)低于无症状女性(75.6%)或有明显症状的女性(80.8%)。有明显症状的女性的特异性(73.7%)低于无症状女性(94.9%)或有其他症状的女性(95.4%)。在筛查期间检测出浸润性癌的女性中,在调整年龄、HRT使用和家族史后,有其他症状的女性比无症状女性更有可能出现假阴性结果(比值比1.79,95%置信区间1.03至3.04)。
有其他症状的女性较低的敏感性需要进一步研究。可能的解释包括乳腺密度增加和图像质量差。有明显症状的女性较高的敏感性可能是由于放射科医生的操作更为谨慎,这也导致了该组较低的特异性。